16. William Haseltine
Human Genome Sciences CEO
William Haseltine, 57, combines a passion for scientific exploration and a talent for directing researchers toward practical and profitable products. By investigating the genes most relevant to pharmaceutical research, Human Genome Sciences is transforming
itself into the world's first genomics-based pharmaceutical behemoth. It already has six drugs in clinical trials, for diseases including lupus, colitis and several chemotherapy-
induced ailments. Haseltine's approach to decoding the genome promises to bring biotech's benefits more quickly
to patients and
shareholders alike.
CNN Video:
Watch a short profile of William Haseltine
Company Web Site: www.hgsi.com
|